Dementia research in 2020: moving forward despite the COVID-19 pandemic.

Kivipelto, Miia; Mangialasche, Francesca

Kivipelto, Miia; Mangialasche, Francesca.

Kivipelto M; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Theme Aging, Karolinska University Hospital, Stockholm, Sweden; The Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK. Electronic address: miia.kivipelto@ki.se.
Mangialasche F; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Aging Research Center, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.

Lancet Neurol ; 20(1): 3-5, 2021 01.

Article in English | MEDLINE | ID: covidwho-978466

Subject(s)

Alzheimer Disease; Alzheimer Disease/blood; Alzheimer Disease/diagnosis; Alzheimer Disease/drug therapy; Alzheimer Disease/prevention & control; Biomarkers/blood; COVID-19; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alzheimer Disease Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Lancet Neurol Journal subject: Neurology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google